Search Results 371-380 of 17467 for Vitiligo

  1. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

    o Subjects with type I diabetes mellitus, hypothyroidism requiring only hormone replacement, skin disorders (such as vitiligo,psoriasis or alopecia) not ...

  2. Dermatology - Doctors - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  3. A Study Using Avelumab in Non-Small Cell Lung Cancer that has Progressed - Mayo Clinic

    vitiligo; psoriasis; hypo- or hyperthyroid disease not requiring immunosuppressive treatment is eligible. Other protocol defined criteria could apply ...

  4. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

    Patients with vitiligo, endocrine deficiencies including thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible.

  5. Acne - Doctors and departments - Mayo Clinic

    ... Vitiligo, Oral lichen planus, Nonmelanoma skin cancer, Tuberous sclerosis, Klippel-Trenaunay syndrome, Melasma, Alopecia areata, Diffuse capillary ...

  6. Bullous pemphigoid - Doctors and departments - Mayo Clinic

    Learn about the symptoms, treatment and self-care strategies for the itchy blisters of this skin condition that affects older adults.

  7. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    ... vitiligo). Participants with Grade 2 toxicities that are deemed stable or irreversible (e.g., chemotherapy related arthritis or tendinitis, skin ...

  8. MEDI5395 Advanced Solid Tumors - Clinical Trials

    Participation eligibility · Vitiligo or alopecia; · Hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement; · Any chronic skin condition ...

  9. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    ... vitiligo, psoriasis, or alopecia) not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger are permitted ...

  10. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    Patients with eczema, psoriasis, lichen simplex chronicus of vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis would ...